Hot Investor Mandate: Venture Builder and Investor Invests up to $1M Globally in Pre-Seed and Seed Stage Companies

29 Dec

The venture fund and venture builder invests in multiple healthcare sectors including therapeutics and synthetic biology, life science tools, IVD, medical devices, digital health and microbiome. The firm invests in pre-seed/seed stage companies with some proof of concept, looking to be the first institutional money in. The firm will invest globally, and looks to invest between $400k-1M. As an igniter, the firm takes a very active role in company formation, development and executive management.

The firm is interested in therapeutics, life science tools, medical devices, synthetic biology, and microbiome related technologies. Within these areas, anything relevant will be considered, including digital health and in vitro diagnostics. The firm is agnostic to indication.

The firm only invests in the first institutional capital round. The firm can invest, or act as a co-founder, depending on the needs of the company/founding team.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: